# Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review Page: https://stenobird.com/podcast/hematologic-oncology-update-916423/relapsed-refractory-multiple-myeloma-microlearning-activity-1-with-dr-sagar-lonial-ash-2025-review Text version: https://stenobird.com/podcast/hematologic-oncology-update-916423/relapsed-refractory-multiple-myeloma-microlearning-activity-1-with-dr-sagar-lonial-ash-2025-review.md Podcast: [Hematologic Oncology Update](https://stenobird.com/podcast/hematologic-oncology-update-916423) Published: 2026-02-03T19:30:00+00:00 Episode link: https://hematologic-oncology.captivate.fm/episode/5608-ashrrmm25-micro-1 Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/664d6119-3fe8-4de0-b2f0-acc94e52c812.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-multiple-myeloma-microlearning-activity-1-with-dr-sagar-lonial-ash-2025-review Duration seconds: 1403 ## Resource Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025. CME information and select publications here . ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-multiple-myeloma-microlearning-activity-1-with-dr-sagar-lonial-ash-2025-review/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/hematologic-oncology-update-916423/relapsed-refractory-multiple-myeloma-microlearning-activity-1-with-dr-sagar-lonial-ash-2025-review.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.